Sino Medical Sciences Technology Inc (SINOMED) is a medical equipment company. It carries out the production and sales of medical devices. The company's product portfolio includes coronary intervention, neuro intervention and structural heart. SINOMED provides a drug-eluting coronary stent, coronary balloon catheter, intracranial balloon dilatation catheter, intracranial drug-eluting stent system and transcatheter mitral valve replacement (TMVR). It offers development, consulting and transferring of intervention technology. SINOMED also provides services after sale services The company’s brands are Tradent, Sc honkytonk, NC Rockstar, Mariyana, Ghunter, Apachi, Cometiu, Optimus, Apex Tera, Rayline and Novarai. It serves the healthcare and hospital sectors. SINOMED is headquartered in Tianjin, China.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Sino Medical Sciences Technology Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Sino Medical Sciences Technology Inc Company Overview
- Sino Medical Sciences Technology Inc Company Snapshot
- Sino Medical Sciences Technology Inc Pipeline Products and Ongoing Clinical Trials Overview
- Sino Medical Sciences Technology Inc - Pipeline Analysis Overview
- Sino Medical Sciences Technology Inc - Key Facts
- Sino Medical Sciences Technology Inc - Major Products and Services
- Sino Medical Sciences Technology Inc Pipeline Products by Development Stage
- Sino Medical Sciences Technology Inc Ongoing Clinical Trials by Trial Status
- Sino Medical Sciences Technology Inc Pipeline Products Overview
- AccuFit Transapical Mitral Valve Replacement Device
- AccuFit Transapical Mitral Valve Replacement Device Product Overview
- BuMA Supreme DES (Drug Eluting Stent)
- BuMA Supreme DES (Drug Eluting Stent) Product Overview
- BuMA Supreme DES (Drug Eluting Stent) Clinical Trial
- Flow Diverter Stent System
- Flow Diverter Stent System Product Overview
- Flow Diverter Stent System Clinical Trial
- SINOMED CBC
- SINOMED CBC Product Overview
- Supreme HT Drug-Eluting Stent
- Supreme HT Drug-Eluting Stent Product Overview
- Supreme HT Drug-Eluting Stent Clinical Trial
- Sino Medical Sciences Technology Inc - Key Competitors
- Sino Medical Sciences Technology Inc - Key Employees
- Sino Medical Sciences Technology Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Sino Medical Sciences Technology Inc, Recent Developments
- Feb 28, 2023: Sino Medical Sciences Technology receives 510(k) clearance for SC HONKYTONK PTCA Balloon Dilatation Catheter
- Jan 03, 2023: Sino Medical Sciences Technology receives 510(k) clearance for NC ROCKSTAR Non-Compliant PTCA Balloon Dilatation Catheter
- Apr 29, 2022: Sino Medical Sciences Technology Announcement on the Appointment of Senior Management
- Oct 27, 2021: SINOMED: HT Supreme Drug Eluting Stent performs equivalent to best-in-class in the PIONEER III publication
- Aug 17, 2021: SINOMED announces the first commercial implantation and European launch of the HT Supreme Drug Eluting Stent
- Jul 05, 2021: SINOMED and NUI Galway partner to study new stenting method
- May 27, 2021: SINOMED announces the HT Supreme DES has similar performance as the market-leader across the spectrum of lesion complexity
- Nov 17, 2020: Late-breaking study results of the Supreme HT healing-targeted des demonstrated equivalent outcomes with exceptional safety
- Jul 13, 2020: SINOMED completes one-year follow-up of the PIONEER-III European, US and Japanese trial of the BuMA Supreme Coronary Drug-Eluting Stent
- Jul 06, 2020: SINOMED completes last patient follow-up of the PIONEER-III pivotal US and Japanese trial of the BuMA Supreme Coronary Drug-Eluting Stent
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Sino Medical Sciences Technology Inc Pipeline Products and Ongoing Clinical Trials Overview
- Sino Medical Sciences Technology Inc Pipeline Products by Equipment Type
- Sino Medical Sciences Technology Inc Pipeline Products by Indication
- Sino Medical Sciences Technology Inc Ongoing Clinical Trials by Trial Status
- Sino Medical Sciences Technology Inc, Key Facts
- Sino Medical Sciences Technology Inc, Major Products and Services
- Sino Medical Sciences Technology Inc Number of Pipeline Products by Development Stage
- Sino Medical Sciences Technology Inc Pipeline Products Summary by Development Stage
- Sino Medical Sciences Technology Inc Ongoing Clinical Trials by Trial Status
- Sino Medical Sciences Technology Inc Ongoing Clinical Trials Summary
- AccuFit Transapical Mitral Valve Replacement Device - Product Status
- AccuFit Transapical Mitral Valve Replacement Device - Product Description
- BuMA Supreme DES (Drug Eluting Stent) - Product Status
- BuMA Supreme DES (Drug Eluting Stent) - Product Description
- BuMA Supreme DES (Drug Eluting Stent) - A Prospective, Multicenter Trial Program in China to Evaluate the Efficacy and Safety of BuMA Supreme (eG Grafting) Biodegradable Polymer Sirolimus Eluting Stent in Patients with de Novo Coronary Lesions, OPC Trial
- Flow Diverter Stent System - Product Status
- Flow Diverter Stent System - Product Description
- Flow Diverter Stent System - A Prospective, Multi-center, Single Arm Clinical Study to Evaluate the Safety and Effectiveness of the Flow Diverter Stent System in the Treatment of Cerebral Aneurysms
- SINOMED CBC - Product Status
- SINOMED CBC - Product Description
- Supreme HT Drug-Eluting Stent - Product Status
- Supreme HT Drug-Eluting Stent - Product Description
- Supreme HT Drug-Eluting Stent - Non-inferiority of Angiography-derived Physiology Guidance Versus Usual Care in an All-comers PCI Population Treated with Unrestricted Use of the Healing-targeted Supreme (HT Supreme) Drug-eluting Stent and P2Y12 Inhibitor Monotherapy after 1-month of Dual-antiplatelet Therapy
- Sino Medical Sciences Technology Inc, Key Employees
- Sino Medical Sciences Technology Inc, Subsidiaries
- Glossary
- Sino Medical Sciences Technology Inc Pipeline Products by Equipment Type
- Sino Medical Sciences Technology Inc Pipeline Products by Development Stage
- Sino Medical Sciences Technology Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Winner Medical Group Co Ltd
- Acotec Scientific Co Ltd
- Zhende Medical Co Ltd
- Shanghai MicroPort Endovascular MedTech Group Co Ltd
